Evidence map›Paper›PMID 40186733›Full record

ArticleInternational urology and nephrology2025

Unveiling trends in urinary tract cancer mortality among older adults in the United States (1999-2022): a CDC WONDER perspective.

Laksh Kumar, Talha Ali, Faiqa Iqbal, Muhammad Ahmed, Bazil Azeem

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laksh KumarShaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.ORCID http://orcid.org/0009-0002-6978-5080
Talha AliShaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan. talhaali190@gmail.com.ORCID http://orcid.org/0009-0000-3208-653X
Faiqa IqbalShaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.ORCID http://orcid.org/0009-0008-5601-1098
Muhammad AhmedShaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.ORCID http://orcid.org/0009-0006-5844-049X
Bazil AzeemShaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.ORCID http://orcid.org/0009-0002-5284-876X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary tract cancers (UTCs), including bladder cancer, remain a significant public health challenge, particularly among individuals aged 75 and older. Despite declining bladder cancer-specific mortality rates between 2015 and 2020, the broader trends in UTC mortality and associated demographic disparities remain underexplored.

methodsWe analyzed mortality data from 1999 to 2022 using the CDC WONDER database. UTC deaths were identified using ICD- 10 codes C64 to C68. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated, stratified by sex, race/ethnicity, and census regions. Joinpoint regression identified annual percent changes (APCs) to assess temporal trends.

resultsFrom 1999 to 2022, 477,157 UTC deaths were recorded, 66% of which occurred among individuals aged 75 and older. The AAMR increased from 97.1 in 1999 to 103.5 in 2022, with a rise between 1999 and 2007 (APC: 0.63%), a decline from 2007 to 2019 (APC: - 0.33%), and a resurgence from 2019 to 2022 (APC: 2.42%). Older males exhibited higher AAMRs than females (178.7 vs. 53.6 in 2022), and Whites had the highest AAMR (108.5) among racial groups. The Western region recorded the highest AAMR (84.3) during the study period.

conclusionThe resurgence in UTC mortality post- 2019 highlights emerging challenges, particularly among older males, Whites, and residents of the Western region. Targeted interventions, including improved screening and equitable healthcare access, are essential to mitigate these disparities and improve outcomes.

Indexed as

Urologic NeoplasmsAgedAged, 80 and overCenters for Disease Control and Prevention, U.S.FemaleHumansMaleMortalityUnited StatesEpidemiologyGender disparitiesMortalityRacial disparitiesUrinary tract neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.